Why Vimian Group stock moves
Vimian Group rose sharply, more than the market.
Written after the close on ·
Why today
15,984 news analyzed todayVimian Group rose sharply, more than the market.
The market rose clearly over the same days, so Vimian Group moved with a stronger push than OMX Stockholm 30.
No company news from the last session explains the move.
Over the last five trading days, Vimian Group rose clearly, while the market rose slightly.
The trading volume was about three times a normal session, and the share is near its highest close of the past year.
Today's move of +2.31% was 2.7 times a normal day's 0.9%. OMX Stockholm 30 moved +0.83% on the same day.
Vimian Group +2.31%OMX Stockholm 30 +0.83%A little stronger than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Vimian Group.
Vimian Group earned more than expected in 1 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 2 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 42.00 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedEUR
Next reported quarter: expected earnings per share of 0.03 EUR (February 11). For the current fiscal year, expected earnings per share changed from 0.11 EUR three months ago to 0.09 EUR now. 2026 estimate: 0.09 EUR. 2027 estimate: 0.12 EUR. One analyst made the estimate for the quarter. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. October 30: Sell about 510 thousand SEK. September 16: Buy about 55 m SEK. September 11: Buy about 67 m SEK. September 10: Buy about 47 m SEK. September 9: Buy about 72 m SEK.
What the key figures say about Vimian Group
The figures connect what Vimian Group earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.02 EUR–0.06 EUR. Peers: BioPorto -0.01 DKK, Inify Laboratories -0.97 NOK, Danaher $6.04. 2026 estimate: 0.09 EUR (0.08 EUR–0.10 EUR). 2027 estimate: 0.12 EUR (0.11 EUR–0.14 EUR).
What the company sold during the year.
2022–2025: 281 m EUR–425 m EUR. Peers: BioPorto 38.4 m DKK, Danaher $25.6B. 2026 estimate: 482 m EUR (477 m EUR–485 m EUR). 2027 estimate: 536 m EUR (525 m EUR–544 m EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: 13.1%–16.1%. Peers: BioPorto −213.7%, Inify Laboratories −370.3%, Danaher 20.4%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −1.4%–4.5%. Peers: BioPorto −25.7%, Danaher 8.2%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 1.76–4.56. Peers: Danaher 2.68.
More key figures
Cash left after investments, divided by the number of shares.
2022–2025: -0.09 EUR–0.17 EUR. Peers: BioPorto -0.16 DKK, Danaher $8.15.
The percentage of assets financed by shareholders’ equity.
2022–2025: 52.2%–63.1%.
What to watch next, and why
The earnings report shows how Vimian Group's revenue and profit have changed.
- Earnings report
The earnings report shows how Vimian Group's revenue and profit have changed.
Add to calendar
More about Vimian Group
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Stefano Santarelli, senior executiveSellabout 510 thousand SEK
- Gabriel Fitzgerald, board member (closely associated)Buyabout 55 m SEK
- Gabriel Fitzgerald, board member (closely associated)Buyabout 67 m SEK
- Gabriel Fitzgerald, board member (closely associated)Buyabout 47 m SEK
- Gabriel Fitzgerald, board member (closely associated)Buyabout 72 m SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Vimian Group usually moved about 7.0%. On a normal day it moves 0.9%.
+5.26% Why? +3.69% +7.99% +11.14%
10,000 SEK in Vimian Group bought on June 18, 2021 is worth 5,200 SEK today, with dividends reinvested.
The same amount in OMX Stockholm 30 with dividends would have become 17,100 SEK.
What would 10,000 SEK in Vimian Group be worth today? →
What would 10,000 SEK in Vimian Group be worth today?
5,200 SEK
with dividends reinvested, bought on June 18, 2021. The same amount in OMX Stockholm 30 with dividends would have become 17,100 SEK.
At worst it was worth 2,560 SEK (October 13, 2023).
The five biggest days of the journey
· +20.1% · the whole market rose 1.1% the same day · report day
· +18.6% · the whole market fell 0.2% the same day
· −13.8% · the whole market fell 0.3% the same day · report day
· +12.7% · the whole market fell 1.0% the same day
· +12.5% · the whole market rose 2.0% the same day
Earlier days
+0.73% market −0.29% Vimian Group rose slightly while the market eased. Read →
Vimian Group rose slightly while the market eased.
No company news from that session explains the move.
Over the last five trading days the stock was roughly unchanged, while the market rose clearly.
Its strong third-quarter report, published before the last session, is likely background.
The next earnings report is due in February 2027.
+0.61% market +3.01% Vimian Group was roughly unchanged over the week's trading days, moving less than the market, which rose clearly. Read →
Vimian Group was roughly unchanged over the week's trading days, moving less than the market, which rose clearly.
The shares rose slightly in the last session, while the broader OMX Stockholm 30 index fell slightly.
The move was ordinary for the stock.
Earlier in the week, analysts including DNB Carnegie and ABG Sundal Collier raised their fair value estimates, the price targets, to 45 kronor after strong third-quarter results, which supports the shares.
+0.63% market +0.33% Vimian Group rose with the market. Read →
Vimian Group rose with the market.
Over the same day the market also rose slightly, so the move was in line with the market.
It was an ordinary day for Vimian Group, within its usual daily range.
Over the last five trading days the shares rose sharply, well ahead of the market, which rose only slightly.
Most of that rise likely reflects the strong third-quarter report released last week, with revenue up 15 per cent and organic growth of 11 per cent.
−1.96% market +1.57% Vimian Group fell clearly without a company-news explanation. Read →
Vimian Group fell clearly without a company-news explanation.
Vimian Group moved against the market in the last session, while OMX Stockholm 30 rose clearly.
Over the last five trading days, the stock rose sharply, even as the market fell slightly.
Its share price is near its highest close of the past year.
+2.12% market +0.41% Vimian Group rose after analysts raised their target prices on Friday. Read →
Vimian Group rose after analysts raised their target prices on Friday.
Vimian Group rose clearly in the last session while the OMX Stockholm 30 rose only slightly, so it moved ahead of the market.
DNB Carnegie and ABG Sundal Collier both raised their price target, the share price they see as fair, to SEK 45 and kept their buy ratings.
Over the last five trading days, Vimian Group rose sharply while the market fell sharply, a big move for this stock.
Trading was well above normal, and the share is at its highest close of the past year.
+6.93% market −3.67% Vimian Group rose sharply over the last five trading days, moving against a market that fell sharply. Read →
Vimian Group rose sharply over the last five trading days, moving against a market that fell sharply.
The rise was a big move for the stock, rare over the past year.
The likely driver was the strong third-quarter report published yesterday, showing revenue growth of 15 per cent and organic growth (sales growth without acquisitions or currency effects) of 11 per cent.
DNB Carnegie also raised its price target, the share price it sees as fair, to SEK 45 from SEK 40.
+5.26% market −2.51% Vimian Group rose very sharply, moving clearly against a falling market. Read →
Vimian Group rose very sharply, moving clearly against a falling market.
Its quarterly report was published that day: revenue grew 15 per cent, with organic growth (growth excluding acquisitions and currency effects) at 11 per cent.
Over the last five trading days the stock rose sharply, while the OMX Stockholm 30 index fell clearly.
The rise was likely driven by the strong report, and the trading volume was well above its usual level.
The next thing to watch is the Capital Markets Day (an event where management sets out long-term targets) on 24 November.
+1.06% market +1.25% Vimian Group rose clearly, moving in line with OMX Stockholm 30, which also rose clearly; no company news came out that day, so the move most likely reflected the broader market rally. Read →
Vimian Group rose clearly, moving in line with OMX Stockholm 30, which also rose clearly; no company news came out that day, so the move most likely reflected the broader market rally.
Over the last five trading days Vimian Group rose sharply, outpacing a slight gain in the index, and its most recent news was an announcement that its third-quarter report comes on Thursday 22 October, which is worth watching as the next company-specific catalyst.
Shares in this kind of healthcare company tend to react strongly to quarterly results and to shifts in risk appetite across the market.
+1.07% market −0.62% Vimian Group rose clearly without any company news in that session. Read →
Vimian Group rose clearly without any company news in that session.
Over the last five trading days the shares rose very sharply, well ahead of OMX Stockholm 30, which also rose but by a clearly smaller amount.
The latest news is only a notice that the third-quarter report comes on 22 October, which does not explain a price move.
The likely drivers are general buying in Nordic healthcare shares and a rebound after the strong run, rather than a specific event.
The next thing to watch is the third-quarter report on 22 October 2026, which often brings larger moves.
+1.08% market −0.02% Vimian Group rose clearly, while the broader market was roughly flat. Read →
Vimian Group rose clearly, while the broader market was roughly flat.
The stock outpaced OMX Stockholm 30 over the five days, which rose slightly.
Watch the third-quarter report next week, which is the event most likely to move the shares decisively.
+3.06% market +0.21% Over the last five trading days the Stockholm-listed healthcare company climbed strongly while the OMX Stockholm 30 index barely moved, so the gain was its own rather than a market-wide one. Read →
Over the last five trading days the Stockholm-listed healthcare company climbed strongly while the OMX Stockholm 30 index barely moved, so the gain was its own rather than a market-wide one.
The only fresh company items were invitations to its third-quarter report and investor audiocast, which set the schedule rather than carry figures, so the likelier driver is anticipation of that report together with a fund reshuffle that dropped the stock from one manager's portfolio.
Watch next week's third-quarter report, where sales growth and margin will be the numbers that matter.
Learn more · Why do stocks go up and down?